Effects of Ninjin’yoeito on Patients with Chronic Obstructive Pulmonary Disease and Comorbid Frailty and Sarcopenia: A Preliminary Open-Label Randomized Controlled Trial
International Journal of Chronic Obstructive Pulmonary Disease · 2024
DOI: 10.2147/copd.s441767 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift International Journal of Chronic Obstructive Pulmonary Disease, 2024. Verfasst von Hiroyuki Ohbayashi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Medical Corporation, Syureikai, Tohno Chuo Clinic, Mizunami City, Gifu, Japan. Hauptthemen laut MEDLINE: Sarcopenia, Pulmonary Disease, Chronic Obstructive, Drugs, Chinese Herbal, Muscle Strength. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Themen: COPD, Gerontologische Pflege
Abstract (Originalsprache)
Purpose
To present the preliminarily findings regarding the effects of a herbal medicine, Ninjin'yoeito, on comorbid frailty and sarcopenia in patients with chronic obstructive pulmonary disease (COPD). Patients and Methods: Patients with COPD (GOLD II or higher) and fatigue were randomly assigned to Group A (n = 28; no medication for 12 weeks, followed by 12-week administration) or B (n= 25; 24-week continuous administration). Visual analog scale (VAS) symptoms of fatigue, the COPD assessment test (CAT), and the modified Medical Research Council (mMRC) Dyspnea Scale were examined. Physical indices such asknee extension leg strength and walking speed, skeletal muscle mass index (SMI), and respiratory function test were also measured.
Results
VAS fatigue scales in Group B significantly improved after 4, 8, and 12 weeks compared to those in Group A (each p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Corporation, Syureikai, Tohno Chuo Clinic, Mizunami City, Gifu, Japan.
ORCID-Profile: Hiroyuki Ohbayashi
Zitieren
APA
Ohbayashi, H., Ariga, M., Ohta, K., Kudo, S., Furuta, O., & Yamamoto, A. (2024). Effects of Ninjin’yoeito on Patients with Chronic Obstructive Pulmonary Disease and Comorbid Frailty and Sarcopenia: A Preliminary Open-Label Randomized Controlled Trial. International Journal of Chronic Obstructive Pulmonary Disease. https://doi.org/10.2147/copd.s441767
Vancouver
Ohbayashi H, Ariga M, Ohta K, Kudo S, Furuta O, Yamamoto A. Effects of Ninjin’yoeito on Patients with Chronic Obstructive Pulmonary Disease and Comorbid Frailty and Sarcopenia: A Preliminary Open-Label Randomized Controlled Trial. International Journal of Chronic Obstructive Pulmonary Disease. 2024. doi:10.2147/copd.s441767
BibTeX
@article{Ohbayashi2024,
author = {Ohbayashi, Hiroyuki and Ariga, Mitsue and Ohta, Kunihiro and Kudo, Sahori and Furuta, Osamu and Yamamoto, Akinori},
title = {Effects of Ninjin’yoeito on Patients with Chronic Obstructive Pulmonary Disease and Comorbid Frailty and Sarcopenia: A Preliminary Open-Label Randomized Controlled Trial},
journal = {International Journal of Chronic Obstructive Pulmonary Disease},
year = {2024},
doi = {10.2147/copd.s441767}
}
EUVIMED